PALI

Palisade Bio, Inc. - Common Stock (PALI)

About Palisade Bio, Inc. - Common Stock (PALI)

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies for inflammatory bowel diseases. Its programs include PALI-2108 and LB1148. The company was founded on September 6, 2011 and is headquartered in Denver, CO.

Details

Daily high

Daily low

Price at open

52 Week High

$2.86

52 Week Low

$0.53

Market cap

368.0M

Dividend yield

0.00%

Volume

600

Avg. volume

2.5M

P/E ratio

-1.99

Palisade Bio, Inc. - Common Stock News